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SUMMARY
Staphylococcus aureus is a major human bacterial pathogen responsible for deep tissue skin 
infections. Recent observations have suggested that rapid, localized digestion of hyaluronic acid in 
the extracellular matrix (ECM) of the dermis may influence bacterial invasion and tissue 
inflammation. In this study we find that cell migration-inducing protein (Cemip) is the major 
inducible gene responsible for hyaluronan catabolism in mice. Cemip−/− mice failed to digest 
hyaluronan and had significantly less evidence of infection after intradermal bacterial challenge by 
S. aureus. Stabilization of large-molecular-weight hyaluronan enabled increased expression of 
cathelicidin antimicrobial peptide (Camp) that was due in part to enhanced differentiation of 
preadipocytes to adipocytes, as seen histologically and by increased expression of Pref1, PPARg, 
and Adipoq. Cemip−/− mice challenged with S. aureus also had greater IL-6 expression and 
neutrophil infiltration. These observations describe a mechanism for hyaluronan in the dermal 
ECM to regulate tissue inflammation and host antimicrobial defense.
In Brief
In this paper, Dokoshi et al. describe how the mammalian hyaluronidase Cemip is induced in the 
dermis during S. aureus infection. Cemip digests hyaluronan in the skin to regulate reactive 
adipogenesis and subsequent antimicrobial activity and skin inflammation.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Graphical Abstract
INTRODUCTION
Staphylococcus aureus (S. aureus) and group A Streptococcus (GAS) are the major bacterial 
pathogens responsible for invasive infections of human skin. The host immune response to 
these pathogens remains incompletely defined. The majority of research has focused on 
mechanisms to limit invasion of these bacteria by the actions of resident and recruited 
immunocytes as well as the innate antimicrobial functions of the epidermis. However, upon 
disruption of the epidermal barrier, S. aureus or GAS encounters a very different physical 
environment in the dermal extracellular matrix (ECM). As a consequence, the virulence of 
these pathogens includes exploitation of ECM components. For example, GAS evades 
resident leukocyte killing by expressing long chains of hyaluronan (HA) on its surface to 
mimic the HA-rich ECM in the surrounding environment of the dermis (Cole et al., 2011; 
Wessels et al., 1991). S. aureus also has adapted to HA and uses its hyaluronidases to 
facilitate virulence (Ibberson et al., 2014, 2016). Currently, the interplay between bacterial 
and host HA catabolic systems has left unanswered the central question of how mammalian 
HA turnover during injury influences microbial resistance. In this study we sought to better 
understand this host response to infection.
HA is a linear polysaccharide found in the ECM of all vertebrates (Hascall et al., 2004; 
Toole, 1991). The functions of HA are diverse, as it is necessary for mammalian 
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development and migration and also serves important functions in cancer and other diseases 
(Toole et al., 2002). Consistent with the important function of HA, the synthesis and 
degradation of this polysaccharide is strictly regulated and in constant dynamic equilibrium 
(Laurent and Fraser, 1992). A family of mammalian HA synthases and hyaluronidases are 
used in a cell- and tissue-specific manner to regulate tissue HA content (Erickson and Stern, 
2012). Importantly, upon injury, HA is rapidly degraded, and this catabolic reaction results 
in important changes in the local immune response (Noble, 2002; Taylor et al., 2007a). HA 
fragments interact with Toll-like receptor 4 to activate cell responses during injury and have 
been proposed to act as a way to complement pathogen detection mechanisms (Taylor et al., 
2004). Bacterial hyaluronidases such as HysA expressed by S. aureus degrade HA 
differently than the mammalian hyaluronidases and thus generate alternative products with 
distinct functions (Ibberson et al., 2016). However, despite the important role of HA during 
injury, the mechanism responsible for local regulation of HA turnover and its contribution to 
host defense against infection has been unknown.
Prior attempts to evaluate the function of previously defined mammalian hyaluronidases had 
not identified the gene responsible for mediating this critical event following infection of the 
skin. Cell migration-inducing protein (Cemip), alias HA-binding protein involved in HA 
depolymerization (HYBID) and KIAA1199, has been recently observed to have functional 
consequences in functions including deafness, bone growth, fibrosis, and tumor invasion 
(Shimoda et al., 2017; Tang et al., 2019; Yoshida et al., 2013; Yoshino et al., 2017, 2018). In 
this study we hypothesized that Cemip may initiate HA breakdown during deep tissue 
infection by S. aureus and could be used to address the role of HA turnover in host defense. 
Our observations show that Cemip is a critical mammalian hyaluronidase and further show 
how regulation of this ECM component is a key regulator of innate antimicrobial defense by 
the dermis.
RESULTS
Cemip Digests Dermal HA during S. aureus Skin Infection
We examined the expression of Cemip in mice following inoculation of S. aureus into the 
dermis to test if this enzyme may be the hyaluronidase responsible for HA degradation 
during skin injury. S. aureus was chosen as the model skin pathogen over GAS because it 
does not synthesize HA itself but does produce a secreted hyaluronidase that confers 
virulence (Ibberson et al., 2014). S. aureus infection significantly increased Cemip mRNA in 
whole skin, but the expression of other murine hyaluronidases (Hyal1, Hyal2, Hyal3, and 
transmembrane protein 2 [TMEM2]) were unchanged (Figure 1A). Immunohistochemical 
analysis of locally infected tissue showed that Cemip was increased in regions where HA 
staining was decreased (Figure 1B). Cemip−/− mice failed to show an increase of Cemip 
mRNA and had a greater amount of HA in the dermis following skin infection (Figures 1B–
1D). Furthermore, the decrease in the size of HA that occurs following infection was 
abolished in Cemip−/− mice (Figure 1E, lanes c and d). Mast cell-deficient mice had less 
Cemip expression, a finding consistent with a role of histamine in the induction of Cemip 
(Figure S1). These observations demonstrate that Cemip promotes digestion of HA in the 
skin during infection by S. aureus.
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Loss of Cemip Increases Resistance against S. aureus
To evaluate the functional significance of HA digestion by Cemip, tissue injury and S. 
aureus survival were measured in the skin of Cemip−/− mice. Three days after S. aureus 
injection, necrotic lesions on Cemip−/− mice were significantly smaller (Figures 2A and 2B), 
and fewer live bacteria were evident in the skin (Figures 2C and 2D). Fewer bacteria were 
also detected in spleens from Cemip−/− mice (Figure 2E). Because the expression of the 
cathelicidin antimicrobial peptide Camp is strongly associated with resistance to bacterial 
skin infections (Nizet et al., 2001), we next assessed the relative expression of Camp in the 
skin of these mice. mRNA for Camp was significantly increased in tissue biopsies from the 
infected site of Cemip−/− mice (Figure 2F), and more cathelicidin protein was observed in 
tissue surrounding the infected area of the dermis (Figures 2G–2I). These observations 
suggest that loss of Cemip function enabled increased Camp expression.
Loss of Cemip Enhances Reactive Adipogenesis
We have recently shown that a major source of cathelicidin expression in the skin comes 
from the local differentiation of preadipocyte fibroblasts into adipocytes, a process we refer 
to as reactive adipogenesis (Zhang et al., 2015). Degradation of HA inhibits the capacity of 
preadipocytes to differentiate into mature adipocytes (Dokoshi et al., 2018; Ji et al., 2014). 
Therefore, we hypothesized that the digestion of HA by Cemip may inhibit the local 
adipogenic response and thus suppress the expression of the antimicrobial peptide by these 
cells. Histological evaluation of the deep dermis showed a greater expansion of 
subcutaneous white adipose tissue (DWAT) after infection in Cemip−/− mice (Figures 3A 
and 3B). Consistent with the observation of enhanced reactive adipogenesis by decreasing 
hyaluronidase activity, there was also significantly increased expression of genes associated 
with adipogenesis in Cemip−/− mice (preadipocyte factor 1 [Pref-1], peroxisome 
proliferator-activated receptor gamma [PPARg], and adiponectin) (Figures 3C–3E). 
Fluorescence-activated cell sorting (FACS) analysis of skin before and after S. aureus 
infection also showed an increase in the population of preadipocytes in the dermis of Cemip
−/−
 mice as defined by CD31-negative, CD45-negative, platelet-derived growth factor 
receptor-α (PDGFRα)-positive, and spinocerebellar ataxia type 1 (SCA1)-positive cells 
(Figures 3F and 3G). Taken together, these data show that loss of Cemip results in an 
increase in dermal reactive adipogenesis.
Loss of Cemip Enhances the Inflammatory Response to Infection
The expression of Camp and other products of reactive adipogenesis can influence 
inflammation that may amplify the host defense against S. aureus (Hancock et al., 2016; 
Zhang et al., 2016). Therefore, we also investigated the influence of Cemip on resident and 
circulating lymphoid populations. FACS analysis of resident skin lymphoid cells revealed 
that Cemip−/− mice had differences in the relative abundance of CD11c dendritic cells, LY6-
G neutrophils, and F4/80/Ly6-C monocytes (Figures 4A–4F). Interestingly, under baseline 
conditions, dendritic cells and neutrophils were both slightly elevated in Cemip−/− mice. 
Following infection, Cemip−/− mice had relatively fewer dendritic cells and higher numbers 
of the CD11b, LY6-G, and F4/80/Ly6C positive populations. Neutrophils are a critical cell 
type for resistance to S. aureus infection, and increased numbers of LY6G-positive 
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neutrophils were evident by immunohistochemistry (Figure 4G), and an increase in IL-6 
mRNA as measured by qPCR (Figure 4H) was detected in the skin of S. aureus-infected 
Cemip−/− mice. We also evaluated systemic responses in Cemip−/− mice infected by S. 
aureus. Cemip−/− mice showed significantly lower fractions of T-box transcription factor 
(Tbet)+, retinoid-related orphan receptor gamma T (RORgt)+, interferon gamma (IFNg)+, 
and IL-17+ T cells in the spleen (Figures S2A–S2F). Overall, the loss of Cemip expression 
resulted in an enhanced local inflammatory response and decreased systemic inflammatory 
response after S. aureus infection.
DISCUSSION
The results of this study highlight the recently appreciated role of the ECM and resident, 
non-lymphoid cells in the dermis to play an important role in host defense against bacterial 
infection. Large-molecular weight HA is highly abundant and is the major component of the 
ECM (Tammi et al., 1994). HA digestion into small fragments after injury has been shown 
to have important implications for inflammatory responses in vivo (Jiang et al., 2005; Muto 
et al., 2014; Noble et al., 1996; Taylor et al., 2004) and can modify infection by GAS 
through digestion of the HA-rich bacterial capsule of this organism (Schommer et al., 2014). 
However, a clear understanding of the mechanism responsible for HA catabolism or its 
connection to host antimicrobial defense has not been previously defined. In this study, we 
show that Cemip is responsible for the increase in endogenous hyaluronidase activity seen 
during deep tissue infection. These observations provide important new insight into the 
mechanisms that function in the dermis to resist invasive S. aureus infection.
Several complementary experimental observations made here support the conclusion that 
Cemip digests HA during skin infection. These include observations of increased transcript 
abundance, increased protein abundance, and decreased large–molecular weight HA 
corresponding to the timing, localization, and hyaluronidase activity of Cemip. There was no 
evidence of an increase in the expression of other hyaluronidases such as Hyal1, Hyal2, 
Hyal3, and TMEM2. HYAL4 has chondroitinase, not hyaluronidase activity (Kaneiwa et al., 
2012), and expression of PH-20 is restricted to testes (Cherr et al., 1996), and these were 
therefore not examined. A loss of hyaluronidase activity was apparent in Cemip−/− mice, as 
they did not show the decrease in the size of HA after infection that was observed in 
controls, and they had less loss of total large–molecular weight HA as measured by staining 
with HA-binding protein or ELISA. It has also been suggested that reactive oxygen species 
are also involved in HA degradation after tissue injury (Bates et al., 1984). Our observations 
do not exclude this as an additional mechanism, or that other enzymes contributed by the 
host or the bacteria themselves could be also contributing to the turnover in HA. On the 
contrary, as it has been estimated that an adult human contains 15 g of HA and that about 
one-third turns over daily (Tammi et al., 1991), it is very likely that other hyaluronidases are 
participating in the steady-state turnover of HA. Furthermore, S. aureus itself can contribute 
hyaluronidase activity to the site of infection through expression of HysA, an enzyme 
secreted by the pathogen and associated with virulence (Ibberson et al., 2014). The findings 
of this report to not exclude contribution of other enzymes to balance of HA but do clearly 
show that Cemip is responsible for a major fraction of the local increase in HA breakdown 
that occurs during S. aureus infection.
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Further studies are required to better define the cell of origin of Cemip, which originally was 
discovered in dermal fibroblasts. In preliminary experiments, we have performed single-cell 
RNA sequencing (RNA-seq) of whole tissue and in vitro analysis of potential candidate cell 
types that may express Cemip. These studies have not yet convincingly defined a primary 
cell type responsible for its synthesis but suggest that a fibroblast cell type may be the 
origin. Cemip has also been shown to be induced by histamine (Yoshino et al., 2018), and as 
histamine in skin is primarily released by mast cells, we examined if these cells could 
contribute to the response we observed. Mast cell-deficient mice had some-what less Cemip 
but were still able to show increased expression after infection (Figure S2).
The most direct explanation for increased resistance to S. aureus in Cemip−/− mice is the 
increase in Camp produced by the rapid, local differentiation of preadipocyte fibroblasts to 
mature fat (Zhang et al., 2015). A persistence of high–molecular weight HA enables this 
adipogenic response and results in much greater expression of Camp in the dermis at the site 
of infection. We have previously shown that increased hyaluronidase-1 activity (in contrast 
with the loss of hyaluronidase activity seen here in Cemip−/− mice) will inhibit reactive 
adipogenesis and Camp expression (Dokoshi et al., 2018). Our findings described in Figures 
2 and 3 show that loss of Cemip enables the skin to respond to S. aureus infection by 
increasing expression of Camp, expanding DWAT and enhancing gene expression associated 
with adipogenesis.
The present observations suggest that local induction of hyaluronidase activity has a 
negative consequence to the host, as it enables greater bacterial proliferation and infection 
than when Cemip is deleted. Why then has this activity been maintained? We speculate that 
the presence of inducible hyaluronidase activity serves two complementary purposes. First, 
prior work has shown that low–molecular weight fragments of HA generated by 
hyaluronidases are potent danger-associated molecular patterns (DAMPs) and serve to alert 
the host of injury even under aseptic conditions (Mummert, 2005; Taylor et al., 2007b; 
Yamasaki et al., 2009). Consistent with the systemic alarmin function of HA fragments as a 
DAMP, we observed a greatly decreased induction of CD4+ cells expressing Tbet, GATA3, 
RORγt, INFγ, and1 IL-17 in Cemip−/− mice following infection. Thus, Cemip may provide 
one of many systemic signals of injury. A second beneficial consequence of transient, 
inducible hyaluronidase activity is that the digestion of HA inhibits excess local 
inflammatory responses. Hyaluronidase expression can inhibit antigen presentation (Muto et 
al., 2014), thus potentially preventing unwanted allergic sensitization to common antigens 
that become accessible during injury. Cemip−/− mice studied here had greater IL-6 and 
neutrophil infiltration, a reaction that may have helped fight infection. However, the 
immunological consequences to infection in Cemip−/− mice are complicated, as a lower 
bacterial burden and higher Camp expression can indirectly alter local innate and adaptive 
immune responses. Furthermore, HA itself influences many different aspects of cell 
differentiation and migration (West et al., 1985). Major clinical developmental phenotypes 
result from mutations in hyaluronidases such as mucopolysaccharidosis type IX from Hyal1 
(Natowicz et al., 1996), bone defects, and cardiopulmonary dysfunction from loss of Hyal2 
(Jadin et al., 2008; Chowdhury et al., 2013). Deafness and other abnormalities are associated 
with defects in HYBID (Shimoda et al., 2017; Tang et al., 2019; Yoshida et al., 2013; 
Yoshino et al., 2017, 2018). Thus, as is frequently the case, this gene has several essential 
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functions that extend beyond the immune defense role we have defined here. Past and 
current findings suggest that the influence of HA turnover on host defense functions is 
complex and likely acts in multiple ways beyond direct antimicrobial activity.
In summary, this work has solved the long unanswered question of what induces digestion of 
HA in the dermis after infection. This further clarifies the molecular steps necessary for the 
dermis to resist deep tissue infection by S. aureus. HA is an essential component of ECM of 
many organs and often exploited by microbes through molecular mimicry. The fundamental 
roles of elements of the ECM in immune defense are specific to context and may vary by 
organ and microorganism. Understanding how the skin initiates the digestion of HA can 
have important diagnostic and therapeutic implications for many infectious and 
inflammatory diseases.
STAR★METHODS
LEAD CONTACT AND MATERIALS AVAILABILITY
This study did not generate new unique reagents. Further information and requests for 
plasmids, resources, and reagents should be directed to and will be fulfilled by the Lead 
Contact, Richard L Gallo (rgallo@ucsd.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals and animal care—Cemip (KIAA1199) KO mice were generated using a gene 
targeting Cre-loxP system as described in the other report (Shimoda et al., 2017; Yoshino et 
al., 2017). Wild-type mice (C57BL/6 mice) and K14-cre transgenic mice were obtained 
from The Jackson Laboratory. Scf.fl/fl mice (a gift from Dr. Dinald at University of 
California San Diego). K14-cre transgenic mice were bred with Scf.fl/fl mice for the 
generation of K14-cre Scf.fl/fl mice. K14-cre littermate controls were used in all 
experiments. All animal experiments were approved by the University of California, San 
Diego, Institutional Animal Care and Use committee. For all animal studies, animals were 
randomly selected without formal pre-randomization and quantitative measurements were 
done without the opportunity for bias.
Bacterial strains—S. aureus strain USA300 is a predominant community-associated 
Methicillin-resistant S. aureus (MRSA) strain and AH4807, a USA300 MRSA strain was 
tested in a manner that was similar to previously described (Muhs et al., 2017; Paharik et al., 
2017), was kindly provided by Alexander Horswill (Deprtment of Immunology & 
Microbiology at the University of Colorado).
Mouse model of S. aureus skin infection—Skin infection experiments were done as 
described before (Nizet et al., 2001). S. aureus strain USA300 was used for infection. In 
brief, the backs of sex-matched and age-matched (8 week to 12 week) adult wild-type or 
Ella/Hyal1 mice were shaved and hair removed by chemical depilation (Nair) then injected 
subcutaneously with 100 μL of a mid-logarithmic growth phase of S. aureus (2× 106 CFU of 
bacteria) in PBS. Mice were sacrificed after day 3 and 8 mm skin punch biopsy comprising 
the center of the injection site was harvested. Infected skin surrounding the infection center 
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(6–8 mm) void of center abscess was carefully dissected out for RNA extraction or CFU 
determination. Skin biopsies were homogenized in 1 mL Trizol (for RNA) or PBS (for CFU 
counting) with 2 mm zirconia beads in a mini-bead beater 16 (Biospect, Bartlesville, OK). 
To count CFU, homogenized skin samples were serially diluted, plated onto Tryptic Soy 
Agar, and enumerated after 18 hours to quantify the CFU per gram of tissue. For in vivo live 
bacterial imaging, mice were imaged under isoflurane inhalation anesthesia (2%). Photons 
emitted from luminescent bacteria were collected during a 1 min exposure using the 
Xenogen IVIS Imaging System and living image software (Xenogen, Alameda, CA). 
Bioluminescent image data are presented on a pseudocolor scale (blue representing least 
intense and red representing the most intense signal) overlaid onto a gray-scale photographic 
image. Using the image analysis tools in living image software, circular analysis windows 
(of uniform area) were overlaid onto regions of interest and the corresponding 
bioluminescence values (total flux) were measured.
Study approval—All animal experiments were approved by the University of California, 
San Diego, Institutional Animal Care and Use committee. For all animal studies, animals 
were randomly selected without formal pre-randomization and quantitative measurements 
were done without the opportunity for bias.
METHOD DETAILS
Chemicals and reagents
Rat anti-Cemip antibodies were provided by KAO company: Rabbit anti-CAMP 
antibodies were made from our lab as described previously (Dorschner et al., 2001); rabbit 
anti-PREF1/DLK antibodies are from Abcam (Cambridge, MA); BODIPY® FL dye was 
purchased from Thermo Fisher (Houston, TX). HA binding protein was purchased from 
Millipore., mouse-Hyal1, Hyal2, KIAA1199, TMEM2, HAS1, HAS2, HAS3, ZFP423, 
Pref1, PPARg, Adipoq, CEBPA, CAMP, IL6, TNF Taqman gene expression assay were 
purchased from Life Technologies Corporation (Grand Island, NY).
Reverse transcription-quantitative PCR (RTqPCR) analyses—RTqPCR was used 
to determine the mRNA abundance as described previously (Morioka et al., 2008). Total 
cellular RNA was extracted using the PureLink RNA Mini Kit (Life Technologies 
Corporation, Grand Island, NY) and mRNA were purified by using Dynabeads mRNA 
Purification Kit(Life technologies). 100 ng of mRNA was reverse transcribed to cDNA using 
iScript cDNA synthesis kit (Bio-Rad Laboratiries, Inc. Hercules, CA). Quantitative, real-
time PCR was performed on the CFX96 real time system (Biorad) using predeveloped 
Taqman gene expression assay (Applied Biosystems). The expression of β-Actin gene was 
used as a house keeping gene to normalize data.
Histology and immunohistochemistry (IHC)—Tissue biopsies were directly 
embedded in OCT compound or paraffin. Paraffin embedded tissues are used for 
Hematoxylin/Eosin (H&E) staining, and frozen sections were fixed in 4% PFA for 20 mins 
or 100% acetone prior to immunofluorescence staining. For IHC, fixed and permeabilized 
frozen tissue sections were blocked with Image-iT FX reagent (Invitrogen) before incubating 
with primary antibodies followed by appropriate 488- or 568-coupled secondary antibodies. 
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Nuclei were counterstained with DAPI. All images were taken with an Olympus BX41 
microscope (widefield) or Zeiss LSM510 confocal microscope as indicated.
Flow cytometry analyses—Colon collected from control or DSS-treated mice was cut 
into small pieces then digested with 2.5 mg/mL Collagenase D and 30 ng/mL DNase1 for 2 
hours at 37°C then filtered through a 30 μm filter to generate single cell suspension for 
FACS analyses. Cells were then stained with zombie violet viability dye (BioLegend, 
423114), blocked with anti-mouse CD16/32 (eBioscience, 14016185), followed by staining 
with antibody cocktails for preadipocytes or immune cells. The antibody cocktail for 
preadipocytes includes AF488-SMA (eBioscience, 53976082), PECy7-CD45 (BioLegend, 
147704), PerCy5.5-CD31 (BioLegend, 102522), PE-Thy1 (BioLegend, 105308), APC-
PDGFRa (eBioscience, 17140181), BV605-SCA1 (BioLegend, 108133) and AF700-CD24 
(BioLegend, 108136). The antibody cocktail for immune cells includes PECy7-CD11b 
(BioLegend, 101216), FITC-Ly6G (eBioscience, 11593182), PE-F4/80 (eBioscience,
12480182), APC-CD11C (BioLegend, 117310), AF700-MHCII (eBioscience, 56532182), 
APC-Cy7-CD3 (BioLegend, 100222), Tbet (Fisher Scientific, 562467), GATA3(BioLegend, 
653807), RORgt (eBioscience, 12–6981-80), IFN-gamma (BioLegend, 505809), IL-17 
(BioLegend, 506929), Foxp3 (eBioscience, 48–5773-80) and Fixable Viability Dye eFluor 
506 (eBioscience, 65–0866-14)FACS analyses for surface expression of preadipocyte or 
immune cell markers were performed by the BD FACSCanto RUO machine and analyzed by 
FlowJo V10 software. Dead cells stained positive with zombie violet dye were excluded 
from the analyses.
Hyaluronan (HA) analysis—Glycosaminoglycan (GAGs), including HA were extracted 
from murine skin as previously described (Muto et al., 2014).Samples were homogenized 
and treated overnight with protease (0.16 mg/ml; Sigma-Aldrich) to degrade protein, 
followed by purification by anion exchange chromatography using DEAE Sephacel 
(Amersham Biosciences). Columns were washed with a low-salt buffer (0.15 M NaCl in 20 
mM sodium acetate; pH 6.0) and eluted with 1 M NaCl. Glycans were desalted by PD10 
(GE Healthcare). HA concentrations were measured ELISA Duo Set (R&D Systems). The 
size distribution of HA was analyzed by agarose gel electrophoresis (Lee and Cowman, 
1994). The HA sample was mixed with TAE buffer containing 2 M sucrose and 
electrophoresed at 2 V/cm for 10 hours at room temperature. The gel was stained overnight 
under light-protective cover at room temperature in a solution containing 0.005% Stains-All 
in 50% ethanol, and destained in water. Hyalose ladders (Hyalose) were used for standards.
QUANTIFICATION AND STATISTICAL ANALYSIS
Experiments were repeated at least three times with similar results. Statistical significance 
was determined using Student’s unpaired two-tailed t test, or one-way ANOVA multiple 
comparison test as indicated in the legend (*p < 0.05, **p < 0.01, ***p < 0.001).
DATA AND CODE AVAILABILITY
The published article includes all datasets generated or analyzed during this study.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Cemip is induced following skin infection and digests hyaluronan
• Hyaluronan is required for optimal reactive adipogenesis and antimicrobial 
activity
• Digestion of hyaluronan by Cemip inhibits reactive adipogenesis
• Cemip loss increases inflammation and antimicrobial activity following skin 
infection
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Figure 1. Cemip Is Necessary for HA Digestion after Infection
(A) The expression of transcripts for five known mammalian hyaluronidases in murine skin 
is shown before and 3 days following infection by S. aureus (n = 4 control or 6 skin 
infection mice/group).
(B) Mouse dermis stained for HA (green) or Cemip (red) or DAPI (blue) in representative 
sections of skin from control and Cemip−/− mice before and 3 days after S. aureus infection. 
Dotted lines outline regions of HA loss. Infection was to the upper right in all fields shown. 
Scale bar, 20 μm.
(C) mRNA expression from skin measured by qPCR for Cemip (n = 6 mice/group).
(D) HA abundance measured by ELISA in skin extracts (n = 3 mice/group).
(E) Gel electrophoresis and staining for HA. (a) Wild-type skin, (b) Cemip−/− skin, (c) wild-
type skin 3 days after S. aureus, and (d) Cemip−/− 3 days after S. aureus. Arrow indicates 
accumulation of low-molecular weight HA as seen only in control mice after S. aureus.
All error bars indicate mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (t test).
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Figure 2. Cemip−/− Mice Resist Infection by S. aureus
(A) Skin lesions on control and Cemip−/− mice 3 days after inoculation with 1 × 106 colony-
forming units (CFU) of S. aureus.
(B) Measurements of lesion size on mice after inoculation with S. aureus as in (A).
(C ) Representative images taken by IVIS.
(D) Quantification of luminescence in region of interest (ROI) of skin from control and 
Cemip−/− mice 3 days after inoculation with 1 × 106 CFU of bioluminescent S. aureus.
(E) CFU count of S. aureus recovered from the spleen 3 days after skin infection as in (A).
(F) mRNA expression from skin measured by qPCR of Camp (n = 6 control and for S. 
aureus+).
(G) Immunohistochemical staining for cathelicidin (red) and DAPI (blue) in representative 
sections of skin from control and Cemip−/− mice 3 days after S. aureus infection. Scale bar, 
50 μm.
(H) Tissue extracts were subjected to immunoblotting analyses for Camp and beta-actin.
(I) Quantification of the ratio of Camp to beta-actin.
All error bars indicate mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (t test).
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Figure 3. Loss of Cemip Enhances Reactive Adipogenesis
(A) Representative histological images of skin from mice at day 0 and 3 days after infection 
with S. aureus. Tissue was stained with H&E. Brackets delineate dermal region occupied by 
adipocytes. Scale bar, 50 μm.
(B) Quantification of the adipose tissue thickness indicated scale bar (n = 8 for control and 
Cemip−/− infection mice/group).
(C-E) qRT-PCR of the relative abundance of transcripts for (C) Pref1, (D) PPARγ, and (E) 
Adipoq as normalized to β-actin (n = 4 for normal condition, n = 8 for infection mice/
group).
(F) Flow cytometry analysis of single-cell suspensions from the skin showing expression of 
PEGFRα from control, Cemip−/−, control infection, and Cemip−/− infection. Cells were 
gated on CD31-negative, CD45-negative, and SCA-1-positive.
(G) Statistical comparison of the percentages of the cells in the indicated gates shown in (F).
All error bars indicate mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (t test).
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Figure 4. Loss of Cemip Enhances Local Skin Inflammation in Response to S. aureus
(A–F) Flow cytometry analysis of single-cell suspensions from the skin showing expression 
of CD11c/MHCII, Ly6G/CD11b, and LyG-C cells isolated from control, Cemip−/− control 
infection, and Cemip−/− infection. Cells were gated on CD3-negative. Numbers represent the 
percentages of the cells in the indicated gate.
(G) Representative sections of skin from control and Cemip−/− mice at 3 days after S. aureus 
infection. Tissues are stained with red with Gr-1 antibody and blue with DAPI. Scale bar, 20 
μm.
(H) qRT-PCR of the relative abundance of transcripts for IL-6 as normalized to β-actin (n = 
4 for normal condition, n = 8 for infection mice/group).
All error bars indicate mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (t test).
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-CAMP (Dorschner et al., 2001) N/A
Anti-PREF1/DLK Abcam Cat# ab21682
BODIPY® Thermo Fisher Cat# A-577
Anti-HA binding protein Millipore Cat# 385910
Anti-Cemip (Shimoda et al., 2017) N/A
zombie violet viability dye BioLegend Cat# 423114
Anti-mouse CD16/32 eBioscience Cat# 14016185
Anti-mouse SMA eBioscience Cat# 53976082
Anti-mouse CD45 BioLegend Cat# 147704
Anti-mouse CD31 BioLegend Cat# 102522
Anti-mouse Thy1 BioLegend Cat# 105308
Anti-mouse PDGFRa eBioscience Cat# 17140181
Anti-mouse SCA1 BioLegend Cat# 108133
Anti-mouse CD24 BioLegend Cat# 108136
Anti-mouse CD11b BioLegend Cat# 101216
Anti-mouse Ly6G eBioscience Cat# 11593182
Anti-mouse F4/80 eBioscience Cat# 12480182
Anti-mouse CD11C BioLegend Cat# 117310
Anti-mouse MHCII eBioscience Cat# 56532182
Anti-mouse CD3 BioLegend Cat# 100222
Anti-mouse Tbet Fisher Scientific Cat# 562467
Anti-mouse GATA3 BioLegend Cat# 653807
Anti-mouse RORgt eBioscience Cat# 12–6981-80
Anti-mouse IFN-gamma BioLegend Cat# 505809
Anti-mouse IL-17 BioLegend Cat# 506929
Anti-mouse Foxp3 eBioscience Cat# 48–5773-80
Bacterial and Virus Strains
S. aureus strain USA300 (Muhs et al., 2017) N/A
Chemicals, Peptides, and Recombinant Proteins
protease Sigma-Aldrich Cat# P1236
DEAE Sephacel Amersham Biosciences Cat# 17070901
Prepacked Disposable PD-10 Columns GE Healthcare Cat# 17085101
Hyalose ladders HiLadder Hyalose Cat# HYA-HILAD-20
Critical Commercial Assays
DuoSet ELISA Ancillary Reagent Kit R&D Systems Cat# DY007
iScript cDNA synthesis kit Bio-Rad Cat# 1708890
PureLink RNA Mini Kit Life Technologies Cat# 12183025
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REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental Models: Organisms/Strains
Mouse:C57BL/6J Jackson Laboratory Stock No: 000664
Mouse:Cemip (KIAA1199) KO KAO (Shimoda et al., 2017) N/A
Mouse:Scf.fl/fl Di Nardo Lab (Wang et al., 2017) N/A
Mouse:B6N.Cg-Tg(KRT14-cre)1Amc/J Jackson Laboratory Stock No: 018964
Oligonucleotides
Actb ThermoFisher Mm02619580_g1
Hyal1 ThermoFisher Mm00476206_m1
Hyal2 ThermoFisher Mm01230688_g1
Hyal3 ThermoFisher Mm00662097_m1
KIAA1199 ThermoFisher Mm00472921_m1
TMEM2 ThermoFisher Mm00459599_m1
HAS1 ThermoFisher Mm03048195_m1
HAS2 ThermoFisher Mm00515089_m1
HAS3 ThermoFisher Mm00515092_m1
ZFP423 ThermoFisher Mm00677660_m1
Pref1 ThermoFisher Mm00494477_m1
PPARg ThermoFisher Mm00440940_m1
Adipoq ThermoFisher Mm00456425_m1
CEBPA ThermoFisher Mm00514283_s1
CAMP ThermoFisher Mm00438285_m1
IL6 ThermoFisher Mm00446190_m1
TNF ThermoFisher Mm00443258_m1
Software and Algorithms
FlowJo FlowJo https://www.flowjo.com/
IVIS living image software Xenogen https://www.perkinelmer.com/
Prism
GraphPad Software https://www.graphpad.com/
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